Named on one round in the feed.
Since 2016-05-17
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Nouscom Nouscom is a biotech company selling cancer-preventing vaccine candidates primarily to healthcare providers and clinical trial organizations. | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $13.6M | 2016-05-17 | [ LEAD ] |